Assured Guaranty

Successful Lehman Brothers Litigation To Yield $103 Million Gain In 2025

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

02 Sep 24

Updated

08 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-0.9%

1.2%

-0.9%

1.2%

You can edit this narrative until May 12 6:03 AM. Then, changes will post as Updates.

Author's Valuation

US$106.515.6% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates9

Shared on 08 May 25

Fair value Increased 0.35%

Shared on 30 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 0.35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 9.09%

Shared on 19 Mar 25

Fair value Increased 1.71%

AnalystConsensusTarget has increased revenue growth from -2.1% to 0.2% and decreased future PE multiple from 19.2x to 17.2x.

Shared on 11 Mar 25

Fair value Decreased 9.87%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

US$106.5

15.6% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

-4.02%

Insurance revenue growth rate

0.28%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.05%

Calculation

US$262.63m

Earnings '28

19.36x

PE Ratio '28

US$5.08b

Market Cap '28

US$5.08b

Market Cap '28

39.80m

No. shares '28

US$127.74

Share Price '28

US$127.74 Share Price '28

Discounted to 2025 @ 6.97% p.a.

US$104.35

Fair Value '25